Cellular Immune Augmentation in Colon and Rectal Cancer

Clinical trial NCT00257322 · COMPLETED

Trial details

NCT number: NCT00257322
Sponsor: University of California, Irvine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colon Cancer Rectal Cancer

Start date: 2003-04-01
Primary completion: 2007-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.